Multiple System Atrophy (MSA) Clinical Trial
Official title:
A Phase 2, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Potential Efficacy of Multiple Doses of ONO-2808 in Patients With Multiple System Atrophy (MSA)
This is a Phase 2, double-blind, parallel-group, placebo-controlled study to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of multiple doses of ONO-2808 in patients with MSA. This is the first study of ONO-2808 in patients with MSA.
The purpose of the study is to evaluate 3 doses of ONO-2808 compared to placebo in MSA patients, including: 1) safety and tolerability, 2) pharmacokinetics, and 3) changes in clinical outcome assessments (COA) and biomarkers considered to be related to the pharmacodynamics and potential efficacy of ONO-2808. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02778607 -
PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UK
|
||
| Completed |
NCT01485549 -
Oligomeric Alpha-synuclein in Multiple System Atrophy
|
||
| Completed |
NCT02796209 -
Norepinephrine Transporter Blockade, Autonomic Failure
|
Phase 2 | |
| Recruiting |
NCT03811808 -
Multiple System Atrophy Multidisciplinary Clinic
|
||
| Completed |
NCT04193527 -
A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients
|
Phase 3 | |
| Completed |
NCT01888185 -
Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)
|
||
| No longer available |
NCT05086094 -
Expanded Access Protocol of Verdiperstat in Patients With Multiple System Atrophy (MSA)
|